Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: Results from the CARDIA study

Translational Psychiatry

Volumn 6, Issue 2, 2016, Pages

  Black, C N ^a   Penninx, B W J H ^a   Bot, M ^a   Odegaard, A O ^b   Gross, M D ^c   Matthews, K A ^d   Jacobs, D R ^e  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ANTIDEPRESSANT AGENT; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; ISOPROSTANE DERIVATIVE; LYCOPENE; XANTHOPHYLL; ZEAXANTHIN; ANTIOXIDANT;

ADULT; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; COMMUNITY SAMPLE; CORONARY RISK; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HEALTH STATUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; OXIDATIVE STRESS; PHYSICAL ACTIVITY; RISK ASSESSMENT; SMOKING; BLOOD; CORONARY ARTERY DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK; SOCIOECONOMICS;

ADULT; ANTIOXIDANTS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; OXIDATIVE STRESS; RISK; SOCIOECONOMIC FACTORS;

EID: 84979896709     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2016.5     Document Type: Article

References (74)

1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163–2196.
2. Penninx BWJH, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013; 11: 129.
3. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763–2774.
4. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH, Zitman FG. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220–229.
5. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31: 2383–2390.
6. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival?. Nat Clin Pract Oncol 2008; 5: 466–475.
7. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symp-toms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006; 63: 273–279.
8. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002; 72: 227–236.
9. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44–84.
10. Black CN, Bot M, Scheffer PG, Cuijpers P, Penninx BWJH. Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psycho-neuroendocrinology 2014; 51C: 164–175.
11. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52: 601–623.
12. Janicki-Deverts D, Cohen S, Matthews KA, Gross MD, Jacobs DRJ. Socioeconomic status, antioxidant micronutrients, and correlates of oxidative damage: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Psychosom Med 2009; 71: 541–548.
13. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE et al. Smoking, smoking cessation, and major depression. JAMA 1990; 264: 1546–1549.
14. Abu-Omar K, Rutten A, Lehtinen V. Mental health and physical activity in the European Union. Soz Praventivmed 2004; 49: 301–309.
15. Sullivan LE, Fiellin DA, O’Connor PG. The prevalence and impact of alcohol pro-blems in major depression: a systematic review. Am J Med 2005; 118: 330–341.
16. Palta P, Samuel LJ, Miller ER 3rd, Szanton SL. Depression and oxidative stress: results from a meta-analysis of observational studies. Psychosom Med 2014; 76: 12–19.
17. Beydoun MA, Beydoun HA, Boueiz A, Shroff MR, Zonderman AB. Antioxidant status and its association with elevated depressive symptoms among US adults: National Health and Nutrition Examination Surveys 2005-6. Br J Nutr 2013; 109: 1714–1729.
18. Milaneschi Y, Bandinelli S, Penninx BW, Corsi AM, Lauretani F, Vazzana R et al. The relationship between plasma carotenoids and depressive symptoms in older persons. World J Biol Psychiatry 2012; 13: 588–598.
19. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007; 22: 67–73.
20. Niki E. Biomarkers of lipid peroxidation in clinical material. Biochim Biophys Acta 2014; 1840: 809–817.
21. Milne GL, Dai Q, Roberts LJ. The isoprostanes-25 years later. Biochim Biophys Acta 2015; 1851: 433–445.
22. Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE et al. Bio-markers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?. Free Radic Biol Med 2005; 38: 698–710.
23. Milne GL, Yin H, Brooks JD, Sanchez S, Jackson Roberts L, Morrow JD. Quantifi-cation of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 2007; 433: 113–126.
24. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and anti-oxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003; 52: 2346–2352.
25. Beydoun MA, Shroff MR, Chen X, Beydoun HA, Wang Y, Zonderman AB. Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys. J Nutr 2011; 141: 903–913.
26. Coyne T, Ibiebele TI, Baade PD, Dobson A, McClintock C, Dunn S et al. Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr 2005; 82: 685–693.
27. Ford ES, Will JC, Bowman BA, Narayan KM. Diabetes mellitus and serum car-otenoids: findings from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 1999; 149: 168–176.
28. Hozawa A, Jacobs DR, Steffes MW, Gross MD, Steffen LM, Lee D-H. Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 2006; 163: 929–937.
29. Sesso HD, Buring JE, Norkus EP, Gaziano JM. Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women. Am J Clin Nutr 2004; 79: 47–53.
30. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson JE, Willett WC. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr 2003; 77: 1390–1399.
31. Eliassen AH, Liao X, Rosner B, Tamimi RM, Tworoger SS, Hankinson SE. Plasma carotenoids and risk of breast cancer over 20 y of follow-up. Am J Clin Nutr 2015; 101: 1197–1205.
32. Jomova K, Valko M. Health protective effects of carotenoids and their interactions with other biological antioxidants. Eur J Med Chem 2013; 70: 102–110.
33. Fiedor J, Burda K. Potential role of carotenoids as antioxidants in human health and disease. Nutrients 2014; 6: 466–488.
34. Meyer KA, Sijtsma FPC, Nettleton JA, Steffen LM, Horn L, Van, Shikany JM et al. Dietary patterns are associated with plasma F2-isoprostanes in an observational cohort study of adults. Free Radic Biol Med 2014; 57: 1–20.
35. Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 2013; 18: 595–606.
36. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988; 41: 1105–1116.
37. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401.
38. Shafer AB. Meta-analysis of the factor structures of four depression ques-tionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 2006; 62: 123–146.
39. Morrow JD, Roberts LJ 2nd. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 1999; 300: 3–12.
40. Gross M, Steffes M, Jacobs DR, Yu X, Lewis L, Lewis CE et al. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA study. Clin Chem 2005; 51: 125–131.
41. Bieri JG, Brown ED, Smith JC. Determination of individual carotenoids in human-plasma by high-performance liquid-chromatography. J Liq Chromatogr 1985; 8: 473–484.
42. Craft NE, Brown ED, Smith JCJ. Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. Clin Chem 1988; 34: 44–48.
43. Gross MD, Prouty CB, Jacobs DRJ. Stability of carotenoids and alpha-tocopherol during blood collection and processing procedures. Clin Chem 1995; 41: S943–S944.
44. Iribarren C, Folsom AR, Jacobs DRJ, Gross MD, Belcher JD, Eckfeldt JH. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. A case-control study. The ARIC Study Investigators. Atherosclerosis risk in communities. Arterioscler Thromb Vasc Biol 1997; 17: 1171–1177.
45. Hozawa A, Jacobs DR, Steffes MW, Gross MD, Steffen LM, Lee D-H. Relationships of circulating carotenoid concentrations with several markers of inflammation, oxi-dative stress, and endothelial dysfunction: the Coronary Artery Risk Development in Young Adults (CARDIA)/Young Adult Longitudinal Trends in Antioxidants (YALT. Clin Chem 2007); 53: 447–455.
46. Beydoun MA, Fanelli-Kuczmarski MT, Kitner-Triolo MH, Beydoun HA, Kaufman JS, Mason MA et al. Dietary antioxidant intake and its association with cognitive function in an ethnically diverse sample of US adults. Psychosom Med 2015; 77: 68–82.
47. Jacobs DRJ P, Hahn LPM, Haskell WLP, Pirie PP, Sidney SM. Validity and reliability of short physical activity history: CARDIA and the Minnesota Heart Health Pro-gram. J Cardiopulm Rehabil 1989; 9: 448–459.
48. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd edn. Lawrence Erlbaum Associates: Hillsdale, NJ, USA, 1988.
49. McMartin SE, Jacka FN, Colman I. The association between fruit and vegetable consumption and mental health disorders: evidence from five waves of a national survey of Canadians. Prev Med 2013; 56: 225–230.
50. Payne ME, Steck SE, George RR, Steffens DC. Fruit, vegetable, and antioxidant intakes are lower in older adults with depression. J Acad Nutr Diet 2012; 112: 2022–2027.
51. Aseervatham GSB, Sivasudha T, Jeyadevi R, Arul Ananth D. Environmental factors and unhealthy lifestyle influence oxidative stress in humans--an overview. Environ Sci Pollut Res Int 2013; 20: 4356–4369.
52. Alberg A. The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 2002; 180: 121–137.
53. Handelman GJ, Packer L, Cross CE. Destruction of tocopherols, carotenoids, and retinol in human plasma by cigarette smoke. Am J Clin Nutr 1996; 63: 559–565.
54. Beydoun MA, Nalls MA, Canas JA, Evans MK, Zonderman AB. Gene polymorphisms and gene scores linked to low serum carotenoid status and their associations with metabolic disturbance and depressive symptoms in African-American adults. Br J Nutr 2014; 112: 992–1003.
55. Hroudová J, Fišar Z. Connectivity between mitochondrial functions and psychiatric disorders. Psychiatry Clin Neurosci 2011; 65: 130–141.
56. Lee S-Y, Lee S-J, Han C, Patkar AA, Masand PS, Pae C-U. Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants. Prog Neuropsycho-pharmacol Biol Psychiatry 2013; 46: 224–235.
57. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 2003; 8: 365–370.
58. Galecki P, Szemraj J, Bienkiewicz M, Zboralski K, Galecka E. Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients. Hum Psychopharmacol 2009; 24: 277–286.
59. Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M et al. Adenosine dea-minase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 2007; 38: 247–252.
60. Cumurcu BE, Ozyurt H, Etikan I, Demir S, Karlidag R. Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin Neurosci 2009; 63: 639–645.
61. Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1284–1290.
62. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001; 64: 43–51.
63. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol Lett 2009; 30: 462–469.
64. Chung CP, Schmidt D, Stein CM, Morrow JD, Salomon RM. Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res 2012; 206: 213–216.
65. Rawdin BS, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y et al. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun 2012; 31: 143–152.
66. Gawryluk JW, Wang J-F, Andreazza AC, Shao L, Yatham LN, Young LT. Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia. Int J Neuropsychopharmacol 2011; 14: 1069–1074.
67. Gawryluk JW, Wang J-F, Andreazza AC, Shao L, Young LT. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 2011; 14: 123–130.
68. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012; 3: CD007176.
69. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev 2008; CD004183.
70. Cortés-Jofré M, Rueda J-R, Corsini-Muñoz G, Fonseca-Cortés C, Caraballoso M, Bonfill Cosp X. Drugs for preventing lung cancer in healthy people. Cochrane Database Syst Rev 2012; 10: CD002141.
71. Satia JA, Littman A, Slatore CG, Galanko JA, White E. Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol 2009; 169: 815–828.
72. Tanvetyanon T, Bepler G. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands. Cancer 2008; 113: 150–157.
73. Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C et al. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials. PLoS One 2014; 9: e96905.
74. Lai JS, Hiles S, Bisquera A, Hure AJ, McEvoy M, Attia J. A systematic review and meta-analysis of dietary patterns and depression in community-dwelling adults. Am J Clin Nutr 2014; 99: 181–197.